Head-To-Head Comparison: Profound Medical (NASDAQ:PROF) and Tenon Medical (NASDAQ:TNON)

Tenon Medical (NASDAQ:TNON) and Profound Medical (NASDAQ:PROF) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, earnings, risk and institutional ownership.

Volatility and Risk

Tenon Medical has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500.

Profitability

This table compares Tenon Medical and Profound Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-257.85%	-907.60%	-124.84%
Profound Medical	-171.57%	-63.03%	-51.24%

Analyst Ratings

This is a summary of recent ratings for Tenon Medical and Profound Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1	0	1	0	2.00
Profound Medical	1	0	1	1	2.67

Profound Medical has a consensus price target of $11.50, suggesting a potential upside of 96.58%. Given Profound Medical’s stronger consensus rating and higher probable upside, analysts clearly believe Profound Medical is more favorable than Tenon Medical.

Valuation & Earnings

This table compares Tenon Medical and Profound Medical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.94 million	0.69	-$12.56 million	($44.87)	-0.09
Profound Medical	$16.10 million	13.28	-$42.57 million	($0.98)	-5.97

Tenon Medical has higher earnings, but lower revenue than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

22.7% of Tenon Medical shares are held by institutional investors. Comparatively, 47.9% of Profound Medical shares are held by institutional investors. 17.7% of Tenon Medical shares are held by insiders. Comparatively, 1.5% of Profound Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Profound Medical beats Tenon Medical on 10 of the 14 factors compared between the two stocks.

About Tenon Medical

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.